lauric acid

lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.

Cross Reference

Introduction

To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with lauric acid?

lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with lauric acid

MeSH term MeSH ID Detail
Prostatic Hyperplasia D011470 20 associated lipids
Brain Infarction D020520 17 associated lipids
Stroke D020521 32 associated lipids
Starvation D013217 47 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cerebral Infarction D002544 6 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Per page 10 20 50 | Total 33

PubChem Associated disorders and diseases

What pathways are associated with lauric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with lauric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with lauric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with lauric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with lauric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with lauric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with lauric acid

Download all related citations
Per page 10 20 50 100 | Total 1837
Authors Title Published Journal PubMed Link
Williams DE et al. Sex differences in cytochrome P-450 isozyme composition and activity in kidney microsomes of mature rainbow trout. 1986 Biochem. Pharmacol. pmid:3718543
Pons N et al. Interaction of polyhalogenated compounds of appropriate configuration with mammalian or bacterial CYP enzymes. Increased bilirubin and uroporphyrinogen oxidation in vitro. 2003 Biochem. Pharmacol. pmid:12907239
Ronis MJ et al. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). 1994 Biochem. Pharmacol. pmid:7986207
Kikuta Y et al. Expression and induction of cytochrome P450s in rabbit parotid glands. 2001 Biochem. Pharmacol. pmid:11389885
Past MR and Cook DE Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450. 1982 Biochem. Pharmacol. pmid:7150359
Kocarek TA and Feller DR Induction of peroxisomal fatty acyl-CoA oxidase and microsomal laurate hydroxylase activities by beclobric acid and two metabolites in primary cultures of rat hepatocytes. 1987 Biochem. Pharmacol. pmid:3632723
Knickle LC et al. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid. 1992 Biochem. Pharmacol. pmid:1380810
Sivapathasundaram S et al. A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver. 2001 Biochem. Pharmacol. pmid:11585060
Amet Y et al. Cytochrome P450 4A and 2E1 expression in human kidney microsomes. 1997 Biochem. Pharmacol. pmid:9113097
Okita RT et al. Lauric acid hydroxylation in human liver and kidney cortex microsomes. 1979 Biochem. Pharmacol. pmid:533546
Hvattum E et al. Microsomal oxidation of dodecylthioacetic acid (a 3-thia fatty acid) in rat liver. 1991 Mar 15-Apr 1 Biochem. Pharmacol. pmid:1672593
Sharma RK et al. Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. 1989 Biochem. Pharmacol. pmid:2554928
Pham MA et al. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. 1989 Biochem. Pharmacol. pmid:2500129
Swinney DC et al. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase. 1991 Biochem. Pharmacol. pmid:1662512
Lundgren B et al. Effects of dietary treatment with 11 dicarboxylic acids, diethylcarboxylic esters and fatty acids on peroxisomal fatty acid beta-oxidation, epoxide hydrolases and lauric acid omega-hydroxylation in mouse liver. 1992 Biochem. Pharmacol. pmid:1540233
Raza H and Levine WG Effect of hypolipidemic drugs on the metabolism of lauric acid and dimethylaminoazobenzene by rat liver microsomes. 1987 Biochem. Pharmacol. pmid:3103631
Byard J et al. Novel approaches to the purification and identification of cytochrome P450 enzymes in the equine. 1996 Biochem. Soc. Trans. pmid:8736866
Gibson GG and Bains SK Cytochrome P-450 isoenzymes involved in fatty acid metabolism. 1985 Biochem. Soc. Trans. pmid:4065418
Makowska JM et al. Species differences in the hepatic response to a potent peroxisome proliferator. 1989 Biochem. Soc. Trans. pmid:2628085
Sherrington EJ et al. Lack of effect of different dietary saturated fatty acids on adipose tissue deposition in the rat. 1996 Biochem. Soc. Trans. pmid:8736816
Abigor RD et al. Lipase-catalysed production of biodiesel fuel from some Nigerian lauric oils. 2000 Biochem. Soc. Trans. pmid:11171279
Zheng YM et al. Covalent heme binding to CYP4B1 via Glu310 and a carbocation porphyrin intermediate. 2003 Biochemistry pmid:12693958
Narayanan VS and Storch J Fatty acid transfer in taurodeoxycholate mixed micelles. 1996 Biochemistry pmid:8652524
Raner GM et al. Regioselective peroxo-dependent heme alkylation in P450(BM3)-F87G by aromatic aldehydes: effects of alkylation on cataysis. 2002 Biochemistry pmid:12135382
Six DA et al. Purification and mutagenesis of LpxL, the lauroyltransferase of Escherichia coli lipid A biosynthesis. 2008 Biochemistry pmid:18656959
Cheng XL et al. The biosynthetic incorporation of short-chain linear saturated fatty acids by Acholeplasma laidlawii B may suppress cell growth by perturbing membrane lipid polar headgroup distribution. 2002 Biochemistry pmid:12093284
Straub P et al. Differential effects of mutations in substrate recognition site 1 of cytochrome P450 2C2 on lauric acid and progesterone hydroxylation. 1994 Biochemistry pmid:8025107
Ost TW et al. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3. 2001 Biochemistry pmid:11695888
CaJacob CA and Ortiz de Montellano PR Mechanism-based in vivo inactivation of lauric acid hydroxylases. 1986 Biochemistry pmid:3490272
Loughran PA et al. Identification of unique amino acids that modulate CYP4A7 activity. 2000 Biochemistry pmid:11106489
Hamilton SE et al. Identification of the high-affinity lipid binding site in Escherichia coli pyruvate oxidase. 1986 Biochemistry pmid:3545288
Modi S et al. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam. 1995 Biochemistry pmid:7619797
Yeom H et al. The role of Thr268 in oxygen activation of cytochrome P450BM-3. 1995 Biochemistry pmid:7578081
Haines DC et al. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel. 2008 Biochemistry pmid:18298086
Gasymov OK et al. Ligand binding site of tear lipocalin: contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid. 2008 Biochemistry pmid:18179255
Murataliev MB and Feyereisen R Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain. 1996 Biochemistry pmid:8942669
Murataliev MB et al. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain. 1997 Biochemistry pmid:9204888
Winkler E et al. Identification of the pH sensor for nucleotide binding in the uncoupling protein from brown adipose tissue. 1997 Biochemistry pmid:8993328
Kantor HL and Prestegard JH Fusion of fatty acid containing lecithin vesicles. 1975 Biochemistry pmid:1125198
Poli-Scaife S et al. The substrate binding site of human liver cytochrome P450 2C9: an NMR study. 1997 Biochemistry pmid:9335524
Davis JH 2H nuclear magnetic resonance of exchange-labeled gramicidin in an oriented lyotropic nematic phase. 1988 Biochemistry pmid:2450569
Haining RL et al. Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding. 1999 Biochemistry pmid:10079071
Makovitzki A and Shai Y pH-dependent antifungal lipopeptides and their plausible mode of action. 2005 Biochemistry pmid:16008362
Richieri GV et al. Binding kinetics of engineered mutants provide insight about the pathway for entering and exiting the intestinal fatty acid binding protein. 1999 Biochemistry pmid:10231541
Noble MA et al. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3. 1998 Biochemistry pmid:9843385
Lawson RJ et al. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. 2004 Biochemistry pmid:15449930
Echtay KS et al. Role of intrahelical arginine residues in functional properties of uncoupling protein (UCP1). 2001 Biochemistry pmid:11318647
Reynolds CM and Raetz CR Replacement of lipopolysaccharide with free lipid A molecules in Escherichia coli mutants lacking all core sugars. 2009 Biochemistry pmid:19754149
Sanghani PC et al. Human glutathione-dependent formaldehyde dehydrogenase. Structures of apo, binary, and inhibitory ternary complexes. 2002 Biochemistry pmid:12196016
Orlowski M et al. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. 1993 Biochemistry pmid:8431436